In the Patient 1 column in Table 1 on page 1913, the “Required ICU admission” row should read “No.” The error has been corrected in the online version of the article.
. 2021 Mar 18;137(11):1561. doi: 10.1182/blood.2021010938
Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients. Blood. 2020;135(21):1912–1915.
Issue date 2021 Mar 18.
Copyright © 2021 American Society of Hematology. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7970664 PMID: 33734339
This corrects the article "The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients" in volume 135 on page 1912.